Oncaspar Drug Interactions: 219 Major, 94 Moderate
Oncaspar (Pegaspargase) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Oncaspar. Always confirm against the full prescribing information.
100 interactions
Allantoin
The therapeutic efficacy of Allantoin can be increased when used in combination with Pegaspargase.
Level 2 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Pegaspargase.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Articaine.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Pegaspargase.
Level 2 evidence
Beclomethasone dipropionate
The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Pegaspargase.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Benzyl alcohol.
Level 1 evidence
Betamethasone
The serum concentration of Betamethasone can be increased when it is combined with Pegaspargase.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Pegaspargase.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Bupivacaine.
Level 1 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Butamben.
Level 1 evidence
Abacavir
Abacavir may increase the hepatotoxic activities of Pegaspargase.
Level 2 evidence
Enter your NPI to unlock 34 major interactions for Oncaspar
Oncaspar (Pegaspargase) has 715 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Oncaspar (Pegaspargase) has 219 major, 94 moderate, and 402 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Oncaspar. Always confirm against the full prescribing information.